Economic Benefits of COVID-19 Screening Tests
Andrew Atkeson, Michael Droste, Michael J. Mina, James H. Stock
doi: https://doi.org/10.1101/2020.10.22.20217984
Andrew Atkeson
1Department of Economics, UCLA
Michael Droste
2Department of Economics, Harvard University
Michael J. Mina
3Chan School of Public Heath, Harvard University
James H. Stock
4Department of Economics and Harvard Kennedy School, Harvard University
Data Availability
All data used ihis paper is derived from publicly available sources and available from the authors upon request.
Posted November 01, 2020.
Economic Benefits of COVID-19 Screening Tests
Andrew Atkeson, Michael Droste, Michael J. Mina, James H. Stock
medRxiv 2020.10.22.20217984; doi: https://doi.org/10.1101/2020.10.22.20217984
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12562)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6783)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)